Noradrenergic innervation does not affect chronic regulation of [125I]pindolol receptors in fetal rat brain transplants or host neocortex

Validation of S-1'-[18F]fluorocarazolol for in vivo imaging and quantification of cerebral beta-adrenoceptors

S-1'-[18F]fluorocarazolol (S-(-)-4-(2-hydroxy-3-(1'-[18F]fluoroisopropyl)-aminopropoxy)carba zole, a non-subtype-selective beta-adrenoceptor antagonist) has been investigated for in vivo studies of beta-adrenoceptors. Previous results indicated that uptake of this radioligand in heart and lung can be inhibited by beta-adrenoceptor agonists and antagonists. In the present study, blocking, displacement and saturation experiments were performed in rats, in combination with metabolite analysis to investigate the suitability of this radioligand for in vivo positron emission tomography (PET) imaging and quantification of beta-adrenoceptors in the brain. The results demonstrate that, (i) the uptake of S-1'-[18F]fluorocarazolol reflects specific binding to beta-adrenoceptors, (ii) binding of S-1'-[18F]fluorocarazolol to atypical or non-beta-adrenergic sites is negligible, (iii) uptake of radioactive metabolites in the brain is less than 25% of total radioactivity, 60 min after injection, (iv) in vivo measurements of receptor densities (Bmax) in cortex, cerebellum, heart, lung and erythrocytes are within range of densities determined from in vitro assays, (v) binding of S-1'-[18F]fluorocarazolol can be displaced. In conclusion, S-1'-[18F]fluorocarazolol seems to possess the appropriate characteristics to visualize and quantify beta-adrenoceptors in vivo in the central nervous system using PET.

The ontogeny of estrogen receptors in heterochronic hippocampal and neocortical transplants demonstrates an intrinsic developmental program

We investigated the intrinsic vs. environmental regulation of estrogen receptor (ER) ontogeny in the neocortex, hippocampus and hypothalamus by employing a heterochronic transplantation paradigm. These studies were based on previous reports demonstrating that neural ER develop asynchronously with quantitatively distinct ontogenetic profiles in various brain regions. Fetal (E14-15) hippocampal, frontal cortical or hypothalamic preoptic area (HPOA) primordial tissue was grafted into frontal cortical lesion cavities made in newborn (PND-0) rats. Thus, the grafted tissue was 1 week younger than the host. Two and 4 weeks following transplantation surgery, which corresponds to a theoretical donor age of PND-7 and PND-21, the grafts, a region of the host neocortex surrounding the transplant, and the host hippocampus, frontal cortex or HPOA (depending on graft type) were assayed for ER content using in vitro binding assays. ER concentration in hippocampal grafts at theoretical age PND-7 were significantly higher than those found in the host (PND-14) hippocampus and in the host neocortex adjacent to the transplant. By theoretical graft age PND-21, ER concentration in hippocampal transplants had decreased to levels comparable to those found in the host. This developmental pattern is analogous to that previously reported for the in situ hippocampus. A similar profile of ER concentration corresponding to the donor age developmental timetable was observed in neocortical grafts. ER levels in HPOA grafts did not change from theoretical donor age PND-7 to PND-21, which also corresponds to the normal ontogenetic profile. These data suggest that region-specific developmental patterns of ER expression in the rat brain are specified by embryonic day 14.

Adult rat barrel cortex plasticity occurs at 1 week but not at 1 day after vibrissectomy as demonstrated by the 2-deoxyglucose method

Stimulation of a single facial vibrissa in rats receiving [14C]2-deoxyglucose leads to increased local cerebral glucose utilization in the corresponding contralateral barrel of lamina IV of the first somatosensory cortex (SmI). In the adult rat, the metabolic representation of such a barrel enlarges 2 months after removal of all other vibrissal follicles but enlargement is prevented by prior removal of SmI norepinephrine. Here, the early time course of such enlargement and how this was affected by cortical norepinephrine manipulations were examined in adult rats. One day after total vibrissal follicle removal with sparing of the central (C3) vibrissa, neither the areal extent nor absolute glucose utilization in the stimulated, spared C3 cortical barrel were changed. However, 7 days after follicle removal, the spared C3 barrel was enlarged by 41%, although absolute glucose utilization remained constant. This delayed onset of enlargement is compatible with either a structural or neurochemical change in barrel circuitry following vibrissal deafferentation. With ipsilateral locus coeruleus lesions but intact vibrissae, there was progressive enlargement of stimulated C3 barrel areas with increasing cortical norepinephrine depletion (r = 0.864) suggesting a suppressive effect of norepinephrine on activity spread in barrels with intact vibrissal afferents. Previously shown blockade of chronic (2 month) vibrissectomy-induced barrel enlargement by norephinephrine depletion suggested an additional effect on plasticity. Even though acute (1 day) follicle removal here produced no change in spared C3 barrel area, addition of norepinephrine depletion produced a surprising 40% decrease in barrel area. Thus, barrel plasticity assessed by 2-deoxyglucose reflects a complex interaction between barrel metabolic activity and the extent of vibrissal and noradrenergic afferent input.

Fetal neocortical transplants into the medial forebrain bundle attract ingrowth of catecholaminergic fibers in adult rat brain

The hypothesis that fetal tissue grafts may exert a trophic influence on damaged catecholaminergic fibers was examined. Ascending dopamine and norepinephrine axons normally innervate frontal cortex targets in the intact rat brain. These and other ascending catecholaminergic fibers were disrupted with stereotaxic injections of 6-hydroxydopamine into the medial forebrain bundle (mfb), followed after 1 or 14 days by grafts of fetal neocortical tissue placed into the injection site, or by sham grafts. Glyoxylic acid histofluorescence techniques were then used to examine catecholaminergic fiber distribution. When such lesions were made without subsequent grafting, virtually no growth of catecholaminergic fibers occurred beyond the injection site and frontal cortex norepinephrine levels were depleted to 15% of control levels. However, when grafts of fetal neocortical tissue were made into the lesion site and animals examined 3 months later, catecholaminergic fibers grew through the lesion site to ramify within the graft tissue. Catecholaminergic fibers were seen in all portions of most grafts, though they were most dense on the caudal and ventral edges of the graft, close to the path of the mfb. Similar densities of graft innervation were seen 3 months after animals received grafts placed into the same site without prior lesioning of catecholaminergic fibers. Fetal neocortical grafts thus induce collateral sprouting from intact host catecholaminergic axons and may also promote regenerative sprouting when such fibers are otherwise irreparably damaged.